X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Merck to Acquire Verona

    Merck to Acquire Verona Pharma in $10B Deal Boosts COPD Drug

    Emerging Oral Small Molecule Drugs

    Emerging Oral Small-Molecule Drugs for Ultra-Rare Diseases

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Merck to Acquire Verona

    Merck to Acquire Verona Pharma in $10B Deal Boosts COPD Drug

    Emerging Oral Small Molecule Drugs

    Emerging Oral Small-Molecule Drugs for Ultra-Rare Diseases

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home News

With A CAGR of 4.5%, Global Fluid Handling Sees New Highs

Content Team by Content Team
8th August 2024
in News

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

The global market for fluid handling systems is expected to grow from USD 72,765.23 million in 2023 to USD 1,08,322.43 million in 2032. The most recent research report by Polaris Market Research projects that between 2024 and 2032, it will grow at a compound annual growth rate (CAGR) of 4.5%.

What is the market size of systems for handling fluids?

In order to transmit the flow and force of an operating fluid to specialized activities like labor, heat transmission, or manufacturing goods, fluid handling systems are often a network of interconnected devices. Fluid management systems are critical to industry. It is not enough to just possess one. It has to be well-defined to be productive, much like other industrial departments. Rendering is more effective and may save time and other resources. It could operate more effectively and last longer if certain sections are improved. Well-made gadgets display high output. This kind of organization, the choice of fluids, and the system’s goal are some of the elements that might vary greatly depending on the intended application.

Among the parts that make up the market are storage tanks, pumps, flow meters, and control valves. Positive ejectors are another category for pumps, and centrifugal pumps are essential for supplying the right fluid flow rates in a range of applications. The chemical industry is a major driver of demand for fluid handling equipment due to its many operations that need solutes, solvents, and utilities like water.

Main Features of the Report:

  • The fluid handling systems market is being propelled by many factors, such as automation, valve technology, and advancements in pump design.
  • Product, application, and geography are the three main variables used in market segmentation.
  • Asia Pacific leads the industry with the largest market share for fluid handling systems.

Major Companies in the Market for Fluid Handling Systems

  • ALFA LAVAL
  • Christian Bürkert GmbH & Co. KG
  • Crane Company
  • Flowserve Corporation
  • Danfoss
  • Dover Corporation
  • CIRCOR International, Inc.

Leading Innovations in the Market

Development Trends and Accelerators:

Growth in the Food Processing industry: One of the main industries using fluid handling systems for a variety of flow operations is the food processing industry. Rising food costs in emerging countries are the driving force behind this growth, which is anticipated to have a positive impact on market expansion soon.

Sensor Technology Development: The development of these systems has been aided by automation, the Internet of Things, and sensor technology. These systems’ ability to monitor and manage fluid transfer processes in real time enhances presentation, lowers mistake rates, and enables predictive maintenance. The market for fluid handling systems is being supported by advancements in pump designs, valve technology, and automation, which enable quicker and more dependable fluid transfer operations while lowering energy consumption and operating expenses.

Reduction of Contamination Risks: The pharmaceutical industry’s growing need for fluid handling systems is a result of strict government rules requiring contamination-liberated functions. By using materials and technologies that minimize the possibility of contamination, these techniques confirm clarity.

Issues

High Investment Costs: The high financial and functional costs of fluid handling systems make acquisitions very challenging. The instruments and framework account for a large amount of the initial capital outlay, whereas maintenance, compliance, and supervision costs are part of the continuing operating costs.

Which Region Leads the Industry for Fluid Handling Systems?

Asia Pacific: The fluid handling systems market was headed by this region, which had the greatest revenue share. The region’s dominance in the market may be due to the growing need for a range of fluid handling system hardware across industries such as water, wastewater, building and construction, energy and power, and oil and gas.

North America: The market for fluid handling systems is anticipated to develop at the quickest rate in North America during the forecast period. This is due to the fact that the US is developing due to the country’s growing requirement for wireless frameworks to monitor instruments and the oil and gas industry’s explosive need for control valves.

Previous Post

Impact of AI On Drug Development And Discovery Process

Next Post

Advances And Challenges In The Gene Therapy Manufacturing

Related Posts

Merck to Acquire Verona
Drug Development

Merck to Acquire Verona Pharma in $10B Deal Boosts COPD Drug

21st July 2025
ChiRhoClin LogiCare3PL Partners for Drug Distribution
News

ChiRhoClin, LogiCare3PL Partners for Drug Distribution

21st July 2025
Thermo Fisher and Sanofi Partners
Manufacturing

Thermo Fisher and Sanofi Partners for US Drug Manufacturing

21st July 2025
EMA Recommendations to Secure Anti D Immunoglobulins Supply
News

EMA Recommendations to Secure Anti-D Immunoglobulins Supply

15th July 2025
FDA Approves Oral Therapy for Treating Hereditary Angioedema
FDA Approvals

FDA Approves Oral Therapy for Treating Hereditary Angioedema

15th July 2025
WuXi Biologics and Virogen Bio partner to advance VG712
News

WuXi Biologics and Virogen Bio partner to advance VG712

19th June 2025
Next Post

Advances And Challenges In The Gene Therapy Manufacturing

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In